Search research articles
Contact Us
Filters
Showing results (91-100 of 172) with videos related to
Page
of 18
Sort By:
Oncotarget
|
April 19, 2014
Pathways and therapeutic targets in melanoma
Emma Shtivelman, Michael Q A Davies, Patrick Hwu, et al.
Plos One
|
May 3, 2011
p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin
Matthias Gutekunst, Moshe Oren, Andrea Weilbacher, et al.
Omics : a Journal of Integrative Biology
|
February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters
Stefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.
Oncogene
|
August 29, 2003
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants
Amir Zalcenstein, Perry Stambolsky, Lilach Weisz, et al.
Cell Death and Differentiation
|
October 15, 2016
TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response
Roi Isaac, Ido Goldstein, Noa Furth, et al.
The EMBO Journal
|
July 12, 2002
Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation
Zehavit Goldberg, Ronit Vogt Sionov, Michael Berger, et al.
Genes & Development
|
June 14, 2017
p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity
Ayala Tovy, Adam Spiro, Ryan McCarthy, et al.
Genes & Development
|
October 3, 2018
Corrigendum: p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity
Ayala Tovy, Adam Spiro, Ryan McCarthy, et al.
Cancer Research
|
January 11, 2013
Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4
Matthias Gutekunst, Thomas Mueller, Andrea Weilbacher, et al.
EMBO Reports
|
July 4, 2009
CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing
Judith Pirngruber, Andrei Shchebet, Lisa Schreiber, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 172) with videos related to
Sort By:
Page
of 18
Oncotarget
|
April 19, 2014
Pathways and therapeutic targets in melanoma
Emma Shtivelman, Michael Q A Davies, Patrick Hwu, et al.
Plos One
|
May 3, 2011
p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin
Matthias Gutekunst, Moshe Oren, Andrea Weilbacher, et al.
Omics : a Journal of Integrative Biology
|
February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters
Stefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.
Oncogene
|
August 29, 2003
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants
Amir Zalcenstein, Perry Stambolsky, Lilach Weisz, et al.
Cell Death and Differentiation
|
October 15, 2016
TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response
Roi Isaac, Ido Goldstein, Noa Furth, et al.
The EMBO Journal
|
July 12, 2002
Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation
Zehavit Goldberg, Ronit Vogt Sionov, Michael Berger, et al.
Genes & Development
|
June 14, 2017
p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity
Ayala Tovy, Adam Spiro, Ryan McCarthy, et al.
Genes & Development
|
October 3, 2018
Corrigendum: p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity
Ayala Tovy, Adam Spiro, Ryan McCarthy, et al.
Cancer Research
|
January 11, 2013
Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4
Matthias Gutekunst, Thomas Mueller, Andrea Weilbacher, et al.
EMBO Reports
|
July 4, 2009
CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing
Judith Pirngruber, Andrei Shchebet, Lisa Schreiber, et al.
Page
of 18